A Multiclinic, Placebo-Controlled, Double-Blind Study of Prostaglandin E1 in Raynaud's Syndrome.

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.44.11.754
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Effectiveness of Ultrasound Therapy in Cervical Myofascial Pain Syndrome: A Double Blind, Placebo-Controlled Study

Turkish Journal of Rheumatology
2010English

Ketanserin in Essential Hypertension: A Double-Blind, Placebo-Controlled Study.

Postgraduate Medical Journal
Medicine
1985English

Recount of Prostaglandin E1 Therapy in a Patient With Raynaud's Phenomenon

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of a Probiotic in Emotional Symptoms of Chronic Fatigue Syndrome

Gut Pathogens
VirologyParasitologyInfectious DiseasesMicrobiologyGastroenterology
2009English

Analgesic Effects of Adenosine in Syndrome X Are Counteracted by Theophylline: A Double-Blind Placebo-Controlled Study

Clinical Science
Medicine
1999English

A Randomized, Double-Blind, Placebo-Controlled Study of Oral Antioxidant Supplement Therapy in Patients With Dry Eye Syndrome

Clinical Ophthalmology
Ophthalmology
2016English

Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia
MedicineNeurology
2020English

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy